MARTINSRIED (dpa-AFX) - Medigene AG (MDGEF.PK) reported first-half net result of a loss of 5.66 million euros, compared to profit of 2.22 million euros last year. Loss per share was 0.15 euros, compared to profit of 0.06 euros per share, last year. The company noted that the preceding year's result was positively influenced by one-time effects and by the revaluation of an investment totaling 2.2 million euros, which was posted for the first six months of 2012.
EBITDA was negative at 4.3 million euros, compared to positive EBITDA of 0.8 million euros, prior year. Excluding the preceding year's one-time effects, EBITDA result improved by 6% compared to last year's reporting period.
Total revenue decreased to 3.21 million euros, compared to 3.30 million euros, last year. Total revenue before one-time effect, rose to 3.21 million euros, from 2.91 million euros, a year ago.
Medigene improved the financial guidance for 2013. The company now expects total revenue to increase to 8 million euros-9 million euros, compared to the previous forecast of 7 million euros-8 million euros, and a loss on an EBITDA basis of 8 million euros-10 million euros, compared to the previous forecast of 9 million euros-11 million euros.
Copyright RTT News/dpa-AFX
© 2013 AFX News
